Literature DB >> 9310522

Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.

M H Cnossen1, E N Stam, L C Cooiman, H J Simonsz, H Stroink, A P Oranje, D J Halley, A de Goede-Bolder, M F Niermeijer, S M de Muinck Keizer-Schrama.   

Abstract

OBJECTIVE: To establish the prevalence of endocrinologic disorders in children with neurofibromatosis type 1 (NF1) and the relationship between these disorders and cerebral abnormalities on magnetic resonance imaging.
DESIGN: A prospective follow-up study. Setting. A multidisciplinary neurofibromatosis clinic. PATIENTS: A total of 122 children diagnosed with NF1 according to diagnostic criteria set by the National Institutes of Health.
RESULTS: Central precocious puberty (CPP) was diagnosed in 3 children and growth hormone deficiency (GHD) in 3 children. Optic pathway gliomas were observed in 15 children; in 9 of the 15 cases, the optic chiasm was involved. Of the 3 children with CPP, only 1 showed a chiasma glioma on magnetic resonance imaging. In 1 case with GHD, an optic chiasm glioma was detected on neuroimaging. Two of the 9 children with an optic chiasm glioma presented with CPP or GHD.
CONCLUSIONS: It has been suggested that CPP in children with NF1 is found exclusively in the presence of a chiasma glioma. We conclude that chiasma glioma may not be obligatory in children with NF1 and CPP or GHD. Moreover, we report a prevalence of GHD in children with NF1 of 2.5%, which has not been established earlier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310522     DOI: 10.1542/peds.100.4.667

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

Review 2.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

3.  Growth in North American white children with neurofibromatosis 1 (NF1).

Authors:  J Szudek; P Birch; J M Friedman
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

4.  Pediatric anterior visual pathway gliomas: trends in fluid and electrolyte dynamics and their management nuances.

Authors:  Devesh K Singh; Sanjay Behari; Awadhesh K Jaiswal; Rabi N Sahu; Arun K Srivastava; Anant Mehrotra; Preeti Dabadgaon
Journal:  Childs Nerv Syst       Date:  2014-12-30       Impact factor: 1.475

5.  Height assessments in children with neurofibromatosis type 1.

Authors:  Elizabeth A Soucy; Dorothy van Oppen; Nicole L Nejedly; Feng Gao; David H Gutmann; Abby S Hollander
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

6.  Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.

Authors:  Sara Lomelino Pinheiro; Joana Maciel; Daniela Cavaco; Ana Abrantes Figueiredo; Inês Lemos Damásio; Sara Donato; João Passos; Joana Simões-Pereira
Journal:  Hormones (Athens)       Date:  2022-10-21       Impact factor: 3.419

7.  Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1.

Authors:  Eleni Magdalini Kyritsi; Maria Hasiotou; Christina Kanaka-Gantenbein
Journal:  Endocrine       Date:  2020-06-09       Impact factor: 3.633

8.  Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.

Authors:  Xuexia Wang; Can-Lan Sun; Lindsey Hageman; Kandice Smith; Purnima Singh; Sunil Desai; Douglas S Hawkins; Melissa M Hudson; Leo Mascarenhas; Joseph P Neglia; Kevin C Oeffinger; A Kim Ritchey; Leslie L Robison; Doojduen Villaluna; Wendy Landier; Smita Bhatia
Journal:  J Clin Oncol       Date:  2017-10-04       Impact factor: 44.544

9.  Boys with precocious or early puberty: incidence of pathological brain magnetic resonance imaging findings and factors related to newly developed brain lesions.

Authors:  Keun Hee Choi; Seung Joon Chung; Min Jae Kang; Ju Young Yoon; Ji Eun Lee; Young Ah Lee; Choong Ho Shin; Sei Won Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-12-31

10.  Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.

Authors:  Karolina Kobus; Daniela Hartl; Claus Eric Ott; Monika Osswald; Angela Huebner; Maja von der Hagen; Denise Emmerich; Jirko Kühnisch; Hans Morreau; Frederik J Hes; Victor F Mautner; Anja Harder; Sigrid Tinschert; Stefan Mundlos; Mateusz Kolanczyk
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.